A Three-Protein Panel to Support the Diagnosis of Sepsis in Children
dc.contributor.author | Pilar Orive, Francisco Javier | |
dc.contributor.author | Astigarraga Aguirre, María Iciar | |
dc.contributor.author | Azkargorta, Mikel | |
dc.contributor.author | Elortza, Felix | |
dc.contributor.author | García Obregón, Susana | |
dc.date.accessioned | 2022-09-27T10:07:20Z | |
dc.date.available | 2022-09-27T10:07:20Z | |
dc.date.issued | 2022-03-12 | |
dc.identifier.citation | Journal of Clinical Medicine 11(6) : (2022) // Article ID 1563 | es_ES |
dc.identifier.issn | 2077-0383 | |
dc.identifier.uri | http://hdl.handle.net/10810/57839 | |
dc.description.abstract | Sepsis is a syndrome without a standard validated diagnostic test. Early recognition is crucial. Serum proteome analysis in children with sepsis may identify new biomarkers. This study aimed to find suitable blood biomarkers for an early diagnosis of sepsis. An analytical observational case-control study was carried out in a single center. Children admitted to a Pediatric Intensive Care Unit with clinical diagnosed sepsis were eligible for study. A proteomic analysis conducted by mass spectrometry was performed. Forty patients with sepsis and 24 healthy donors were recruited. Proteomics results revealed 44 proteins differentially expressed between patients and healthy controls. Six proteins were selected to be validated: lactoferrin, serum amyloid-A1 (SAA-1), complement factor B, leucine-rich alpha-2 glycoprotein (LRG1), soluble interleukin-2 alpha chain receptor (sCD25) and soluble haptoglobin-hemoglobin receptor. Our results showed that sCD25, SAA-1, and LRG1 had high levels of specificity and sensitivity, as well as an excellent area under the ROC curve (>0.9). Our study provides a serum proteomic analysis that identifies new diagnostic biomarkers in sepsis. SAA-1, sCD25 and LRG1 were able to separate septic from healthy donor, so they could be used together with other clinical and analytical features to improve sepsis diagnosis in children. | es_ES |
dc.description.sponsorship | This work was funded by Research Projects from University of Basque Country (US10/02) and from the Basque Government (SAIO10-PE10BF02, SAIO12-PE12BF002, 2012111052, 2019111056). CICbioGUNE is supported by Basque Department of Industry, Tourism and Trade (Etortek and Elkartek programs), the Innovation Technology Department of the Bizkaia County, the ProteoRed-ISCIII (Grant PRB3 IPT17/0019), CIBERehd Network and Severo Ochoa Grant (SEV-2016-0644). | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | MDPI | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.subject | mass spectrometry analysis | es_ES |
dc.subject | proteome | es_ES |
dc.subject | sepsis | es_ES |
dc.subject | septic shock | es_ES |
dc.subject | children | es_ES |
dc.subject | biomarkers | es_ES |
dc.subject | campaign international guidelines | es_ES |
dc.subject | management | es_ES |
dc.subject | proteomics | es_ES |
dc.title | A Three-Protein Panel to Support the Diagnosis of Sepsis in Children | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). | es_ES |
dc.rights.holder | Atribución 3.0 España | * |
dc.relation.publisherversion | https://www.mdpi.com/2077-0383/11/6/1563/htm | es_ES |
dc.identifier.doi | 10.3390/jcm11061563 | |
dc.departamentoes | Fisiología | es_ES |
dc.departamentoes | Pediatría | es_ES |
dc.departamentoeu | Fisiologia | es_ES |
dc.departamentoeu | Pediatria | es_ES |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).